Commonwealth loses appeal in clopidogrel PBS damages undertaking case: important lessons for patentees and generics alike

27 June 2023 - Commonwealth claims on the damages undertaking remain a live issue for patentees and generics to consider. ...

Read more →

Chinese stealing health and medical research data: report

21 August 2019 - The global healthcare sector, including Australia, faces increasing cyber threats and malicious activity from Chinese groups, ...

Read more →

Competition watchdog’s appeal over Pfizer ruling dismissed

19 October 2018 - The High Court has dismissed the ACCC’s application to appeal a decision on whether Pfizer’s local ...

Read more →

Commonwealth of Australia v Sanofi: hearing of Commonwealth's claim commences in Federal Court of Australia

31 August 2017 - A six-week hearing in the Federal Court of Australia commenced this week to decide whether the Commonwealth ...

Read more →

Brenzys lists on the Australian PBS and Pfizer denied discovery of documents to establish grounds for patent infringement

4 April 2017 - As of 1 April 2017, Samsung Bioepis' Brenzys, a biosimilar to Pfizer's Enbrel (etanercept), will join ...

Read more →

$30m damages for infringement of Bayer’s Australian Yasmin patent - a “small” jurisdiction with big benefits

29 March 2017 - In a recent landmark Australian Federal Court decision, Bayer v Generic Health FCA 250, Bayer was awarded ...

Read more →

Federal Court of Australia dismisses preliminary discovery application regarding biosimilar suspected of infringing manufacturing process patents

26 March 2017 - In the recent decision of Pfizer Ireland Pharmaceuticals v Samsung Bioepis, Justice Stephen Burley of the Federal ...

Read more →

When is applying for listing on the Pharmaceutical Benefits Scheme not an infringement?

16 February 2017 - In the most recent judgement in the Australian Lyrica litigation, Nicholas J has delivered an interesting decision ...

Read more →

Productivity Commission draft report on intellectual property arrangements

29 April 2016 - Medicines Australia notes the release of the draft report from the Productivity Commission concerning Australia’s Intellectual Property ...

Read more →

Big pharma gaming patents for extra cash: Productivity Commission

29 April 2016 - Global pharmaceutical giants are boosting revenues by unnecessarily extending patents in Aus­tralia, which is also slowing access ...

Read more →